What happened
HLB Therapeutics updated the terms of convertible bonds to raise US$8.04M, about 4.2% of its market value.
For context, this raise equals about 4.2% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Convertible bonds |
|---|---|
| Raise amount | US$8.04M |
| vs. market value | 4.2% |
| Filed | 2026-08-21, [Amended] Material event report (rights offering) |
| Source | DART rcept 20260821000008 → open original filing |
Versions of this filing
- 2026-08-07Original
- 2026-08-21Amendment 1 (this page)
Source: DART. Information only, not investment advice.